Bristol-Myers Squibb Reports Q4 Earnings, Beats EPS Estimates

Bristol-Myers Squibb Co. reports Q4 earnings with a decrease from last year but still beats analyst expectations. The company has shown promising revenue growth despite lower earnings.

Date: 06-02-2025

AI Rating: 6

Earnings Per Share (EPS): Bristol-Myers Squibb's earnings decreased significantly, coming in at $0.04 per share compared to $0.87 per share last year. However, the adjusted earnings of $1.67 per share beat analyst expectations of $1.47, indicating a slight positive sentiment despite the overall decline.

Revenue Growth: The company's revenue rose by 7.5%, reaching $12.342 billion, an increase from $11.477 billion the previous year. This growth in revenue can reflect positively on the company's market position and may support stock prices in the future.

Net Income: The reported net income was $72 million for the quarter, a drastic drop from $1.762 billion in the previous year. While this is a significant decline, the market may react more favorably due to the revenue growth and adjusted earnings performance.

Conclusion: Overall, while the drastic fall in net income and EPS is concerning, the surpassing of EPS estimates and strong revenue growth could reassure investors, mitigating some negative sentiment.

Stocks: BMY